
The PLUSS Trial
@plusstrial
Intratracheal budesonide + surfactant to ⬆️ survival free of BPD in extremely preterm infants | @nhmrc @MCRI_for_kids @chiesigroup @thrasherfund
ID: 908811185461460993
http://www.plusstrial.org 15-09-2017 21:54:06
172 Tweet
758 Followers
0 Following


The The PLUSS Trial was published today:


Link to Editorial of the The PLUSS Trial results by Erik Jensen Children's Hospital: jamanetwork.com/journals/jama/…

In extremely preterm infants receiving surfactant, early intratracheal budesonide may have little to no effect on survival free of bronchopulmonary dysplasia. The PLUSS Trial ja.ma/4frrMQI


Did your baby participate? Published today in JAMA - the results of The The PLUSS Trial! 21 NICUs in 4 countries - Australia, New Zealand, Canada & Singapore - enrolled just over 1060 babies. Brett J. Manley 🤷🏼♂️ joins us! WATCH THE FULL EPISODE --> youtu.be/IVNvO505-So?si…

Wonderful commentary by NeonatalResearch on the context and results of the The PLUSS Trial! #neotwitter neonatalresearch.org



The most recent AAP Neonatal Journal Club webinar is available - youtu.be/beh82Mgor7Q Dr. Aung (Neonatal-Perinatal Fellow, St. Christopher's Hospital) gave an excellent overview of the PLUSS trial. Thank you to Brett J. Manley 🤷🏼♂️ and Dr. Watterberg for joining! #neotwitter Neo Kids On The Block

Today the The PLUSS Trial was awarded the ACTA: Australian Clinical Trials Alliance Clinical Trial of the Year!!! As always the first people to thank are the incredible families and babies of who took part in the trial 🙏🏻 And of course thanks and congratulations to the entire The PLUSS Trial team! #neoTwitter


Huge congratulations to the The PLUSS Trial team and our amazing statisticians, Kate Francis and Susan Donath, for their double win at the ACTA: Australian Clinical Trials Alliance Trial of the Year Awards! 🎉The ACTA STInG Excellence in Statistics Award recognizes their commitment to rigorous trial methodologies.